Published in Neuropharmacology on October 01, 1983
Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A (1999) 3.42
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
A real-time RT-PCR method for the universal detection and identification of flaviviruses. Vector Borne Zoonotic Dis (2007) 2.05
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology (1997) 1.76
Identification of Rickettsia spp. and Bartonella spp. in ffrom the Thai-Myanmar border. Ann N Y Acad Sci (2003) 1.76
The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci (2000) 1.72
Antinociceptive activitiy of narcotic agonist and partial agonist analgesics and other agents in the tail-immersion test in mice and rats. Neuropharmacology (1976) 1.61
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol Cell Neurosci (2001) 1.58
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol (2000) 1.55
Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic. J Clin Microbiol (1988) 1.54
SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci (2001) 1.44
Distribution of Crimean-Congo hemorrhagic fever viral antibody in Senegal: environmental and vectorial correlates. Am J Trop Med Hyg (1990) 1.40
HFRS after a wild rodent bite in the Haute-Savoie--and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet (1984) 1.38
Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October-November 2010. Euro Surveill (2010) 1.38
[Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic (author's transl)]. Bull Soc Pathol Exot Filiales (1982) 1.38
Orexin-A, an hypothalamic peptide with analgesic properties. Pain (2001) 1.20
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]. Med Trop (Mars) (1981) 1.16
Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci Lett (2003) 1.16
First human case of haemorrhagic fever with renal syndrome in the Central African Republic. Trans R Soc Trop Med Hyg (1987) 1.13
A comparison of rectal and subcutaneous body temperature measurement in the common marmoset. J Pharmacol Toxicol Methods (1998) 1.10
Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué. Trans R Soc Trop Med Hyg (1982) 1.10
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav (1991) 1.08
Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. Trans R Soc Trop Med Hyg (1990) 1.06
[Dengue in Burkina Faso (ex-Upper Volta): seasonal epidemics in the urban area of Ouagadougou]. Bull Soc Pathol Exot Filiales (1985) 1.06
Changes in Rift Valley fever neutralizing antibody prevalence among small domestic ruminants following the 1987 outbreak in the Senegal River basin. Res Virol (1991) 1.06
The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol (1998) 1.05
An arenavirus isolated from wild-caught rodents (Pramys species) in the Central African Republic. Intervirology (1983) 1.05
[Crimean-Congo hemorrhagic fever in Senegal. Latest data on the ecology of the CCHF virus]. Bull Soc Pathol Exot (1994) 1.05
Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. Trans R Soc Trop Med Hyg (1994) 1.05
The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B. Br J Pharmacol (2008) 1.03
Evolution of the Old World Arenaviridae and their rodent hosts: generalized host-transfer or association by descent? Infect Genet Evol (2001) 1.02
Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1989) 1.02
Insect densoviruses may be widespread in mosquito cell lines. J Gen Virol (1995) 1.01
Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behav Brain Res (2005) 1.00
Clinical aspects and usefulness of indirect absorbed immunofluorescence for diagnosis of yaws in Central Africa. J Clin Microbiol (1988) 0.96
[Antibodies against the Marburg virus among human populations in the southeastern Central African Republic]. C R Seances Acad Sci III (1981) 0.96
(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist. J Med Chem (1998) 0.96
Proceedings: Modification of the antinociceptive activity of narcotic agonists and antagonists by intraventricular injection of biogenic amines in mice. Br J Pharmacol (1974) 0.96
Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol (1999) 0.95
[Parasites of fresh water turtles in Tunisia]. Arch Inst Pasteur Tunis (1978) 0.93
Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement. Psychopharmacology (Berl) (2001) 0.93
Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav (2004) 0.92
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl) (1992) 0.92
The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception. Eur J Pharmacol (1999) 0.92
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist. Br J Pharmacol (2000) 0.89
The potential role of rodents in the enzootic cycle of Rift Valley fever virus in Senegal. Microbes Infect (2000) 0.89
Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity. Peptides (2005) 0.89
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) (2001) 0.89
[Current serologic data on viral hemorrhagic fevers in the Central African Republic]. Bull Soc Pathol Exot Filiales (1987) 0.89
Evolutionary biology of a Lassa virus complex. Med Microbiol Immunol (1986) 0.89
True HIV-1 infection in a pygmy. Lancet (1987) 0.88
[Descriptive epidemiology of Rift Valley fever in small ruminants in Southern Mauritania after the 1988 rainy season]. Rev Elev Med Vet Pays Trop (1990) 0.88
Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. Eur J Pharmacol (1983) 0.88
SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia (2000) 0.88
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol (2009) 0.88
Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behav Brain Res (2004) 0.88
[Serological approach to the occurrence of rickettsioses in the Central African Republic]. Bull Soc Pathol Exot Filiales (1985) 0.88
Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception. Eur J Pharmacol (1989) 0.87
Sizing up human health through remote sensing: uses and misuses. Parassitologia (2005) 0.87
Differentiation of potent mu and kappa-opiate agonists using heat and pressure antinociceptive profiles and combined potency analysis. Eur J Pharmacol (1982) 0.87
Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. Trans R Soc Trop Med Hyg (1994) 0.85
Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorg Med Chem Lett (1999) 0.85
Serological study of hantavirus in the rodent population of Nakhon Pathom and Nakhon Ratchasima Provinces Thailand. Southeast Asian J Trop Med Public Health (2000) 0.85
Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic. Trans R Soc Trop Med Hyg (1985) 0.85
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs (1989) 0.85
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties. Psychopharmacology (Berl) (1993) 0.84
Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res (2001) 0.84
Further case of haemorrhagic fever with renal syndrome in France. Lancet (1983) 0.83
Comparison of Lassa, Mobala, and Ippy virus reactions by immunofluorescence test. Lancet (1985) 0.83
GABA(B) receptor isoforms GBR1a and GBR1b, appear to be associated with pre- and post-synaptic elements respectively in rat and human cerebellum. Br J Pharmacol (1999) 0.83
[Arbovirosis from Central African Republic: incidence, diagnosis in human pathology (author's transl)]. Med Trop (Mars) (1981) 0.83
Analgesic actions of mu- and kappa-opiate agonists in rats. Arch Int Pharmacodyn Ther (1983) 0.83
Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranes. Br J Pharmacol (1997) 0.83
Serological evidence of endemic Zinga virus and Rift Valley Fever virus in Central African Republic. Lancet (1983) 0.82
Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa. Med Microbiol Immunol (1986) 0.82
Transmission of Crimean-Congo haemorrhagic fever virus from experimentally infected sheep to Hyalomma truncatum ticks. Res Virol (1992) 0.82
Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett (2002) 0.82
Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453. Cephalalgia (2000) 0.82
Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. Eur J Pharmacol (1995) 0.81
Serological evidence for Hantaan-related virus in Africa. Lancet (1984) 0.81
Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine. Vaccine (1985) 0.81
Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635. Br J Pharmacol (2000) 0.81
[Preliminary note on the presence of antibodies to Ebola virus in the human population in the eastern part of the Central African Republic]. Bull Soc Pathol Exot Filiales (1981) 0.81
Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes. Br J Pharmacol (2001) 0.81
[Epidemiological study of arboviruses in the Central African Republic: demonstration of Chikungunya virus during 1978 and 1979]. Bull Soc Pathol Exot Filiales (1981) 0.81
Proceedings: Biogenic amines and the anti-nociceptive activity of agents with a non-opiate-structure. J Pharm Pharmacol (1974) 0.81
The role of biogenic agents in the actions of centrally-acting analgesics. Prog Med Chem (1977) 0.81
Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine. Neuropharmacology (1980) 0.80
Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine. Pharmacol Biochem Behav (2002) 0.80
[Current problems of arboviruses in central Africa]. Bull Soc Pathol Exot Filiales (1988) 0.80
Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan. Psychopharmacology (Berl) (1988) 0.80
[Ebola and Marburg hemorrhagic fever viruses: update on filoviruses]. Med Trop (Mars) (2011) 0.80
[Experimental transmission of Crimean-Congo hemorrhagic fever virus by Rhipicephalus evertsi evertsi (Acarina:Ixodidae)]. Bull Soc Pathol Exot (1999) 0.79
The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res (2007) 0.79
The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan. Cephalalgia (2000) 0.79
The role of opioid receptor sub-types in tifluadom-induced feeding. J Pharm Pharmacol (1984) 0.79